Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin for prevention of COVID-19 in adults in Brazil
ISRCTN90437126Phase 3Completed
- Sponsor
- Universidade Federal de Pernambuco
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in coronavirus disease 2019 (COVID-19) comparing Ivermectin with Placebo (2 arms). Primary endpoint: COVID-19 case diagnosis. Started Sep 2020; status: completed.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ISRCTN90437126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN90437126.